Immunohistochemical assessment of PD-L1 expression using three different monoclonal antibodies in triple negative breast cancer patients

BACKGROUND: PD-L1 receptor expression in breast cancer tissue can be assessed with different anti-human PD-L1 monoclonal antibodies. The performance of three specific monoclonal antibodies in a head-to-head comparison is unknown. In addition, a potential correlation of PD-L1 expression and clinico-p...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmidt, Gilda, Guhl, Margit Maria, Solomayer, Erich-Franz, Wagenpfeil, Gudrun, Hammadeh, Mohammed Eid, Juhasz-Boess, Ingolf, Endrikat, Jan, Kasoha, Mariz, Bohle, Rainer Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Gynecologic Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519646/
https://www.ncbi.nlm.nih.gov/pubmed/35377046
http://dx.doi.org/10.1007/s00404-022-06529-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519646/
https://www.ncbi.nlm.nih.gov/pubmed/35377046
http://dx.doi.org/10.1007/s00404-022-06529-w

Ejemplares similares